Wednesday’s HotCopper trends: BPM Minerals, Cynata Therapeutics, Pathkey.AI and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can move markets. That’s why getting in front of those red-hot trends is key for every trader worth their salt.

In this daily HotCopper Trends column, we break down the top Oz stocks through each trading day.

BPM Minerals (ASX: BPM) took off on news the first hole drilled into a six km Bonnie & Clyde soil anomaly intersected high-grade gold at the Forelands project in the Eastern Goldfields of WA.

Key assay results from the first two RC holes ever drilled at the Bonnie & Clyde prospect include 4.0m at 20.57 grams per tonne (g/t) from 39m, including 1.0m at 73.33 g/t from 40m, and 8.0m at 9.23 g/t from 71m, including 1.0m at 64.71 g/t from 72m.

CEO, Oliver Judd, said the gold is in basement rocks, directly under the soil anomaly, beneath 15 to 30 metres of cover, in the same high-grade metamorphic rocks that host Tropicana.

“We don’t know yet what Bonnie & Clyde is. We do know that 36 more holes from the broader prospect are at the laboratory, with an additional 44 from Beachcomber behind them, so results will keep coming through this quarter and into early 2027.”

Cynata Therapeutics (ASX: CYP) grabbed attention on HotCopper after it confirmed it had raised a total of approximately $912,962 from its fully underwritten pro-rata renounceable entitlement offer.

Additionally, the company has been advised by the underwriter of the entitlement offer, Caravel Securities, that firm commitments have been received for a placement to raise a further $550,000.

The proceeds of the placement will be used to provide the company with greater flexibility to pursue potential transactions to secure rights to new assets, in addition to paying for the costs of the offer and providing further working capital.

Cynata Therapeutics core asset is currently the Cymerus platform, which offers a differentiated approach to manufacturing mesenchymal stromal cells at commercial scale from a single, consistent cell source.

Pathkey.AI (ASX: PKY) rose after its Chipforge project was validated by an independent expert.

The Chipforge platform was used to take written design requirements through to working FPGA hardware, without assistance from the Chipforge team or manual changes to the generated code.

Designing custom hardware normally passes through several specialist steps, each with its own tools and people. Chipforge brings those steps into one platform. Chipforge is in pre-production release and is delivering supported projects with its engineers while the broader product release is targeted for Q1 2027.

“I’m really excited by the results of this independent review,” CEO Andrew Farnsworth, said.

“Through direct prompting, the platform guided the expert through planning and specification, then code development and the verification cycle, including creating the test benches and running the simulations.

“From there it moved through synthesis, generated the bitstream, deployed it to the physical hardware and ran the tests successfully. All of that happened with no intervention or support from the Chipforge team, which is very encouraging to see.”

Looking wider, the S&P/ASX 200 was lower today, dropping 46.30 points or 0.52% to 8,840.50. The bottom performing stocks in this index were 4DMedical and Generation Development Group down 5.39% and 4.14% respectively. Over the last five days the index is virtually un-changed but is currently 4.91% below its 52-week high.

Elsewhere, household spending rose 0.6% in September 2026, according to seasonally adjusted figures released today by the Australian Bureau of Statistics (ABS).

This follows a fall of -0.1 per cent in August and a rise of 1.0 per cent in July.

“Household spending rose across essential and discretionary categories, with both transport and health rising by 1.5% and recreation and culture rising by 0.8%,” said Tom Lay, ABS head of business statistics.

“The rise in transport reflected higher spending on fuel, vehicle repairs and maintenance, and domestic air travel as people travelled to attend major sporting events.”

Fuel spending rose 5.4% in September, reflecting higher global oil prices and the end of the fuel excise relief on 3 August.

Experimental data produced by the ABS suggests that the volume of fuel spending fell by 2.2 per cent in September. This followed a 0.6 per cent fall in Aug

Health spending rose because of higher spending on GP visits, dental and optometric services, as well as pharmaceutical and toiletry goods.

“It’s likely that the late flu activity added to higher health spending in September, driving greater demand for GP consultations and medicines,” Mr Lay said.

That’s Wednesday’s HotCopper Market Trends, I’m Colin Sandell-Hay ⁠- see you for close.